An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
NCT00002272
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Herpes Simplex
HIV Infections
Interventions
DRUG:
Foscarnet sodium
Sponsor
Astra USA